J P MORGAN CHASE & CO Insider Trading $NTII NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
Get free email notifications about insider trading for J P MORGAN CHASE & CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of J P MORGAN CHASE & CO. J P MORGAN CHASE & CO is 10% Owner in ALPHARMA INC ($ALO) and 10% Owner in BEAR STEARNS COMPANIES INC ($BSC) and 10% Owner in JPMORGAN CHASE & CO ($JPM) and 10% Owner in NUCO2 INC /DE ($NUCO) and 10% Owner in CHINDEX INTERNATIONAL INC ($CHDX) and 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and 10% Owner in OGLEBAY NORTON CO /OHIO/ ($OGLE) and 10% Owner in NUVEEN ARIZONA DIVIDEND ADVANTAGE MUNICIPAL FUND 2 ($NKR) and 10% Owner in MYOGEN INC ($MYOG) and 10% Owner in POLAROID HOLDING CO ($UNLISTED).
J P MORGAN CHASE & CO in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of J P MORGAN CHASE & CO: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 18 2008
$NTII Market Capitalization: $405285.00
$NTII Previous Close: $0.02
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of J P MORGAN CHASE & CO in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALO, BSC, CHDX, JPM, MYOG, NTII, NUCO, NKR, OGLE, UNLISTED
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.48 | 2,962,340 | 1,410,666 | 0 | 3 M to 0 (-100.00 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.44 | 158,300 | 69,652 | 2,962,340 | 3.1 M to 3 M (-5.07 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.50 | 211,100 | 105,550 | 3,120,640 | 3.3 M to 3.1 M (-6.34 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.47 | 3,304 | 1,553 | 3,331,740 | 3.3 M to 3.3 M (-0.10 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.55 | 17,900 | 9,845 | 3,335,044 | 3.4 M to 3.3 M (-0.53 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.53 | 41,550 | 22,022 | 3,352,944 | 3.4 M to 3.4 M (-1.22 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.66 | 24,320 | 16,051 | 3,394,494 | 3.4 M to 3.4 M (-0.71 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.65 | 2,700 | 1,755 | 3,418,814 | 3.4 M to 3.4 M (-0.08 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.63 | 29,150 | 18,365 | 3,421,514 | 3.5 M to 3.4 M (-0.84 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.72 | 71,100 | 51,192 | 3,450,664 | 3.5 M to 3.5 M (-2.02 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.78 | 163,567 | 127,582 | 3,521,764 | 3.7 M to 3.5 M (-4.44 %) |
| Oct 20 2008 | NTII | NEUROBIOLOGICAL TE ... | J P MORGAN CHASE & CO | 10% Owner | Sell | S | 0.89 | 38,423 | 34,196 | 3,685,331 | 3.7 M to 3.7 M (-1.03 %) |
Page: 1